Target intelligence / Profile preview

Multiple immune and vascular cell populations via secreted mediators and cell-cell contact

01

Overview

The term 'Multiple immune and vascular cell populations via secreted mediators and cell-cell contact' does not refer to a specific molecular target, such as a single receptor or enzyme. Instead, it describes a complex physiological or pathological environment, most commonly the tumor microenvironment (TME) or an inflammatory niche, where various cell types interact (National Cancer Institute, 2024). These interactions are governed by paracrine signaling through secreted mediators like cytokines, chemokines, and growth factors, as well as juxtacrine signaling through direct physical contact between cell-surface receptors and ligands (Nature Reviews Molecular Cell Biology, 2021). In drug discovery, this phrase is often used to describe the broad scope of action for multi-targeted therapies, such as multi-kinase inhibitors or immunotherapies, that aim to reprogram the collective behavior of a cellular landscape rather than inhibiting a single protein (Cell, 2020). Because it encompasses a wide array of distinct proteins and cell types, it is considered a descriptive physiological state or mechanism of action rather than a discrete therapeutic target (FDA, 2023).

Other names
Tumor microenvironment interactionsNeurovascular unit signalingMulticellular signaling niche
02

Mechanism of action

Not applicable as this represents a complex biological system rather than a single molecular target.

03

Biological functions

Immune responseAngiogenesisCell-cell signalingParacrine signalingJuxtacrine signaling
04

Disease associations

CancerInflammationCardiovascular diseaseAutoimmune disease
05

Safety considerations

Systemic toxicity due to broad cellular involvementOff-target effects in healthy vascular and immune nichesUnpredictable cytokine release or immune-mediated adverse events

Beyond the preview

Go deeper on Multiple immune and vascular cell populations via secreted mediators and cell-cell contact.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multiple immune and vascular cell populations via secreted mediators and cell-cell contact.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call